These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15632084)

  • 1. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation.
    Marchetti S; Gimond C; Chambard JC; Touboul T; Roux D; Pouysségur J; Pagès G
    Mol Cell Biol; 2005 Jan; 25(2):854-64. PubMed ID: 15632084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
    Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G
    J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
    Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
    J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
    Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
    J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.
    Kassel O; Sancono A; Krätzschmar J; Kreft B; Stassen M; Cato AC
    EMBO J; 2001 Dec; 20(24):7108-16. PubMed ID: 11742987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
    Pettiford SM; Herbst R
    Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
    Li B; Yang L; Shen J; Wang C; Jiang Z
    Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
    Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
    EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
    Srivastava N; Sudan R; Saha B
    J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.
    Tárrega C; Ríos P; Cejudo-Marín R; Blanco-Aparicio C; van den Berk L; Schepens J; Hendriks W; Tabernero L; Pulido R
    J Biol Chem; 2005 Nov; 280(45):37885-94. PubMed ID: 16148006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.
    Ward Y; Gupta S; Jensen P; Wartmann M; Davis RJ; Kelly K
    Nature; 1994 Feb; 367(6464):651-4. PubMed ID: 8107850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity.
    Muda M; Theodosiou A; Gillieron C; Smith A; Chabert C; Camps M; Boschert U; Rodrigues N; Davies K; Ashworth A; Arkinstall S
    J Biol Chem; 1998 Apr; 273(15):9323-9. PubMed ID: 9535927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter.
    Ekerot M; Stavridis MP; Delavaine L; Mitchell MP; Staples C; Owens DM; Keenan ID; Dickinson RJ; Storey KG; Keyse SM
    Biochem J; 2008 Jun; 412(2):287-98. PubMed ID: 18321244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
    Camps M; Nichols A; Gillieron C; Antonsson B; Muda M; Chabert C; Boschert U; Arkinstall S
    Science; 1998 May; 280(5367):1262-5. PubMed ID: 9596579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.